Title : miR-26b enhances the sensitivity of hepatocellular carcinoma to Doxorubicin via USP9X-dependent degradation of p53 and regulation of autophagy.

Pub. Date : 2021

PMID : 33767588






3 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 miR-26b enhances the sensitivity of hepatocellular carcinoma to Doxorubicin via USP9X-dependent degradation of p53 and regulation of autophagy. Doxorubicin tumor protein p53 Homo sapiens
2 Delivery of the proteasome inhibitor, MG132, reversed the inhibitory effect of miR-26b on the level of p53 following doxorubicin treatment. Doxorubicin tumor protein p53 Homo sapiens
3 Our current data indicate that miR-26b enhances HCC cell sensitivity to doxorubicin through diminishing USP9X-mediated p53 de-ubiquitination caused by DNA damaging drugs and autophagy regulation. Doxorubicin tumor protein p53 Homo sapiens